Details

Autor(en) / Beteiligte

• Stone, Gregg W
• Lansky, Alexandra J
• Pocock, Stuart J
• Gersh, Bernard J
• Dangas, George
• Wong, S. Chiu
• Witzenbichler, Bernhard
• Guagliumi, Giulio
• Peruga, Jan Z
• Brodie, Bruce R
• Dudek, Dariusz
• Möckel, Martin
• Ochala, Andrzej
• Kellock, Alison
• Parise, Helen
• Mehran, Roxana

Titel

Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction

Ist Teil von

• The New England journal of medicine, 2009-05, Vol.360 (19), p.1946-1959

Ort / Verlag

Waltham, MA: Massachusetts Medical Society

Erscheinungsjahr

2009

Link zum Volltext

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• Acute ST-segment elevation myocardial infarction is often treated with immediate coronary stenting of the infarct-related artery. The use of a paclitaxel-eluting stent, as compared with a bare-metal stent, reduced the risk of restenosis and was equally safe. Acute ST-segment elevation myocardial infarction is often treated with immediate coronary stenting of the infarct-related artery. The use of a paclitaxel-eluting stent, as compared with a bare-metal stent, reduced the risk of restenosis and was equally safe. By enlarging luminal dimensions and sealing dissection planes at the site of coronary-artery occlusion in patients with evolving ST-segment elevation myocardial infarction, bare-metal stents reduce the risk of early and late recurrent ischemia and reocclusion of the infarct-related artery, as compared with balloon angioplasty alone, decreasing the need for subsequent revascularization of the target lesion with repeat percutaneous coronary intervention (PCI) or coronary-artery bypass grafting. 1 , 2 Nonetheless, restenosis occurs in more than 20% of patients in whom bare-metal stents are implanted during primary PCI, and implantation of bare-metal stents, as compared with balloon angioplasty, has not reduced the rates of . . .